Drubay, V.; Skrypek, N.; Cordiez, L.; Vasseur, R.; Schulz, C.; Boukrout, N.; Duchêne, B.; Coppin, L.; Van Seuningen, I.; Jonckheere, N.
TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Phosphorylation on S727. Cancers 2018, 10, 254.
https://doi.org/10.3390/cancers10080254
AMA Style
Drubay V, Skrypek N, Cordiez L, Vasseur R, Schulz C, Boukrout N, Duchêne B, Coppin L, Van Seuningen I, Jonckheere N.
TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Phosphorylation on S727. Cancers. 2018; 10(8):254.
https://doi.org/10.3390/cancers10080254
Chicago/Turabian Style
Drubay, Vincent, Nicolas Skrypek, Lucie Cordiez, Romain Vasseur, Céline Schulz, Nihad Boukrout, Belinda Duchêne, Lucie Coppin, Isabelle Van Seuningen, and Nicolas Jonckheere.
2018. "TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Phosphorylation on S727" Cancers 10, no. 8: 254.
https://doi.org/10.3390/cancers10080254
APA Style
Drubay, V., Skrypek, N., Cordiez, L., Vasseur, R., Schulz, C., Boukrout, N., Duchêne, B., Coppin, L., Van Seuningen, I., & Jonckheere, N.
(2018). TGF-βRII Knock-down in Pancreatic Cancer Cells Promotes Tumor Growth and Gemcitabine Resistance. Importance of STAT3 Phosphorylation on S727. Cancers, 10(8), 254.
https://doi.org/10.3390/cancers10080254